BioCentury
ARTICLE | Company News

Innovative Diagnostic Laboratory LLP sales and marketing update

January 27, 2014 8:00 AM UTC

Innovative Diagnostic launched the ColonSentry blood test in the U.S. to assess a patient's risk for colorectal cancer. The company launched the blood-based test for seven mRNA biomarkers of colorectal cancer on a limited basis late last year. Innovative Diagnostic also received rights to distribute and perform the EarlyCDT-Lung test in the U.S. from Health Diagnostic Laboratory Inc. (Richmond, Va.). EarlyCDT-Lung is an autoantibody blood test against a panel of six tumor-related antigens. Health Diagnostic has exclusive, U.S. rights to market and perform the EarlyCDT-Lung test from Oncimmune Ltd. (Nottingham, U.K.) (see BioCentury, Oct. 28, 2013). ...